Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma
- Citation:
- Blood Adv vol 8 (6) 1464-8
- Year:
- 2024
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Meta-Analysis
- Data Sharing:
- Alliance-data-source,-internal-user
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 13
- Parents:
- 3972
- Children:
- None
- Pharmas:
- Celegene (CALGB 50803), GSK (CALGB 50901 and 50904)
- Grants:
- U10CA180821, U10CA180882, UG1CA233339, UG1CA233247
- Corr. Author:
- Authors:
- Sarah C. Rutherford Jun Yin Levi D. Pederson Kristie A. Blum Peter Martin Sin-Ho Jung Barbara Grant Cara Rosenbaum Bruce D. Cheson Nancy L. Bartlett Sumithra J. Mandrekar John P. Leonard
- Networks:
- CAPITAL, LAPS-IL057, LAPS-MN026, LAPS-MO011, LAPS-OH007, NY018
- Study
- Alliance-A151737
- Multiple Studies, or Legacy Studies in Alliance Study:
- Alliance-A051103, CALGB-50701, CALGB-50803, CALGB-50901, CALGB-50904
- Phases:
- N/A, 1, 2
- Keywords: